The renin-angiotensin system in experimental radiation nephropathy

被引:47
作者
Cohen, EP
Fish, BL
Moulder, JE
机构
[1] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA
来源
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 2002年 / 139卷 / 04期
关键词
D O I
10.1067/mlc.2002.122279
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Irradiation of the kidneys is followed by a well-defined sequence of changes leading eventually to kidney failure. In the rat, inhibition of angiotensin-converting enzyme or blockade of angiotensin 11 receptors can prevent the structural and functional changes that occur after kidney irradiation. These interventions are particularly effective between 3 and 10 weeks after irradiation. However, in a series of studies with the rat model we failed to find any evidence that the renin-angiotensin system (RAS) is activated in the first 10 weeks after kidney irradiation. First, if the RAS was activated during this interval, one would expect hypertension followed by proteinuria and azotemia. However, hypertension is significant only at the end of this period and is preceded by significant proteinuria and azotemia. This evolution is not in favor of an obviously activated RAS during the 3- to 10-week postirradiation interval that is critical for interventions aimed at the RAS. Second, plasma renin activity and active plasma renin protein concentrations are not significantly increased over the first 10 weeks after irradiation. Third, whole-blood and intrarenal angiotensin 11 levels are not increased and may even be decreased over this interval. This last observation is particularly important because the assay used is sensitive enough to detect the effects of dietary salt manipulation. We hypothesize that even the normal activity of the RAS contributes to injury after kidney irradiation, possibly by supporting the proliferation of cells that carry potentially lethal radiation injuries.
引用
收藏
页码:251 / 257
页数:7
相关论文
共 24 条
[1]   Successful brief captopril treatment in experimental radiation nephropathy [J].
Cohen, EP ;
Fish, BL ;
Moulder, JE .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 129 (05) :536-547
[2]   The role of nitric oxide in radiation nephropathy [J].
Cohen, EP ;
Fish, BL ;
Moulder, JE .
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 1996, 104 (02) :200-206
[3]   Angiotensin II infusion exacerbates radiation nephropathy [J].
Cohen, EP ;
Fish, BL ;
Moulder, JE .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (03) :283-291
[4]   Radiation nephropathy after bone marrow transplantation [J].
Cohen, EP .
KIDNEY INTERNATIONAL, 2000, 58 (02) :903-918
[5]  
COHEN EP, 1994, J LAB CLIN MED, V124, P371
[6]   Radiation nephropathy caused by yttrium 90 [J].
Cohen, EP ;
Moulder, JE ;
Robbins, MEC .
LANCET, 2001, 358 (9287) :1102-1103
[7]  
COHEN EP, 1998, CURRENT RAD ONCOLOGY, P94
[8]  
FISHER ER, 1968, LAB INVEST, V19, P530
[9]   Renal toxicity after allogeneic bone marrow transplantation: The combined effects of total-body irradiation and graft-versus-host disease [J].
Miralbell, R ;
Bieri, S ;
Mermillod, B ;
Helg, C ;
Sancho, G ;
Pastoors, B ;
Keller, A ;
Kurtz, JM ;
Chapuis, B .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :579-585
[10]   Angiotensin II receptor antagonists in the prevention of radiation nephropathy [J].
Moulder, JE ;
Fish, BL ;
Cohen, EP ;
Bonsib, SM .
RADIATION RESEARCH, 1996, 146 (01) :106-110